Investing
Stocks Climb Back to Their Pre-Lehman Disaster Level
Stocks closed broadly higher Tuesday, helped by more deal activity in the financial sector and upbeat earnings from the tech sector. After more than two years, the market has regained all its losses following the implosion of Lehman Brothers in September 2008.
For Boeing, the 787 Dreamliner Nightmare Just Won't Stop
Based on a Seattle Times report, it looks likely that the 787 -- already three years late -- is saddled with enormous technical problems that could delay it two more years and cost Boeing $12 billion, 120% more than its original budget.
Daily Blogwatch: Legal Blogs for Superheroes?
Among Tuesday's top online stories for investors: Internet ad revenue is now higher than newspaper revenue; Facebook stock is likely trading at a 300 P/E ratio; 20 world records that were set in 2010.
Asian Investors Continue to Put Money into Chinese Real Estate
Asian markets rose Tuesday. In Hong Kong the Hang Seng Index rose 1.6% and in China the Shanghai Composite Index racked up a 1.8% gain as investors continue to put their money into property. Japan's Nikkei 225 Index gained 1.5%.
Ernst & Young May Face Fraud Charges in the Lehman Debacle
Accounting giant Ernst & Young is expected to face civil fraud charges by New York prosecutors over its alleged role in the spectacular collapse of Lehman Brothers. The lawsuit would mark the first time a Big Four accountant has been charged in regard to the financial crisis.
Why Gold Is Up 420%: Investors Swallowed the SPDR Gold Trust
Gold is on a record bull run, up from $328 in 2002 to $1,375 an ounce today. What caused that steep rise wasn't any inherent increase in gold's value to society, but a clever marketing scheme that allowed it to be traded easily without the hassle of physical delivery: The SPDR Gold ETF.
Some of Monday's top online stories for investors, including: What a McCain-Palin victory might have looked like; how gold and silver could go ballistic by year end; and why Groupon is a real business.
Inside Wall Street: Two Biotechs Locked in Battle Over a Smallpox Vaccine
Two biotechs, SIGA and PharmAthene, vying to establish a foothold in the potentially vast biodefense market are in the midst of duking it out in a multibillion dollar legal battle. The crux of the dispute is a smallpox vaccine being developed for the military.
It Could Be a Happy New Year for Stocks
Improving economic conditions, strong corporate profits and the Fed's easy money have some money managers bullish on equities going into 2011. Plus, companies are staring to deploy their cash hoards on M&A;, dividends and share buybacks. [Video]
After the long downturn, the coming year will be an opportunity for many industries to rejuvenate themselves. Independent researcher IBISWorld sorted through data on 711 U.S.-based industries to come up with these predictions of the 10 best.
DailyFinance Wire
- Nielsen Report: Many DVR Viewers Play the Commercials
- Verizon to Unveil 4G Android Smartphone and Tablet in January?
- 'Call of Duty: Black Ops' Video Game Sales Soar Past $1 Billion
- Stocks Climb Back to Their Pre-Lehman Disaster Level
- Where Are Jobs Going Now? Peru, Bulgaria, Bangladesh. . .
- Merck KGaA Is Latest Pharma to Settle Justice Department Claims
- Census: South Leads US in Fastest Population Growth
- China State Grid buys Brazil power assets for $1B
- Asia shares higher as bank deal boosts Wall St
- NY AG sues Ernst & Young in Lehman probe
- Japan exports post better growth in November
- Hurd in the crosshairs: SEC probe seen as limited
- Deutsche Bank to pay over $550M in fraud probe
- Banking, other deals drive stock indexes higher
- 'Spider-Man' stunt goes awry; is show in peril?